Listen to POA Chairman Dr. Chadi Nabhan highlight the new and informative content in this winter edition of the Caris Connection e-newsletter.
Tune in to hear POA Chairman Dr. Chadi Nabhan interview many of today’s leading experts as they discuss the latest developments in the fields of oncology and precision medicine.
Host: Dr. Chadi Nabhan
Guest: Dr. Daniel Geynisman
Fox Chase Cancer Center
Headquartered in Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute is the only hospital in Michigan focused solely on fighting cancer.
Tune in to hear Dr. Chadi Nabhan and today’s leading oncology experts discuss the latest developments and breakthroughs in the fields of oncology and precision medicine.
A blood test to decipher the molecular composition of a cancer may have been the makings of a scene in Star Trek some years ago, but today is rapidly becoming a standard-of-care approach to help guide clinical management of patients. Learn about the new Caris liquid biopsy assay on the horizon.
Caris Molecular Tumor Board (CMTB) – Case Study: The CMTB works one-on-one with oncologists to interpret molecular findings and provide therapeutic guidance on difficult-to-treat cases. Read how the CMTB approached a 57-year old patient with metastatic extrahepatic bile duct cancer.
Contact Caris Precision Oncology Alliance
If you would like additional information on the POA, have questions, comments, or ideas, we’d love to hear from you. Please click on the link below.